CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		71,474,581
Beginning balance at Dec. 31, 2022	$ 1,270,666	$ 1	$ 1,174,594	$ (155,947)	$ 259,197	$ (7,179)
Treasury stock, shares, beginning balance (in shares) at Dec. 31, 2022				20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		467,594
Issuance of common stock	94,705		94,705
Issuance of common stock under employee plans, net (in shares)		1,441,279
Issuance of common stock under employee plans, net	$ (107,894)		(107,894)
Stock options exercised (in shares)	1,907,000	1,907,026
Stock options exercised	$ 54,503		54,503
Stock-based compensation	131,358		131,358
Issuance of common stock for business combination contingent consideration and related tax effects (in shares)		10,944
Issuance of common stock for business combination contingent consideration and related tax effects	144		144
Net income	175,783				175,783
Other comprehensive income (loss), net	(3,500)					(3,500)
Ending balance (in shares) at Dec. 31, 2023		75,301,424
Ending balance at Dec. 31, 2023	1,615,765	$ 1	1,347,410	$ (155,947)	434,980	(10,679)
Treasury stock, shares, ending balance (in shares) at Dec. 31, 2023				20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee plans, net (in shares)		804,780
Issuance of common stock under employee plans, net	$ (58,178)		(58,178)
Stock options exercised (in shares)	510,000	510,000
Stock options exercised	$ 14,576		14,576
Stock-based compensation	382,604		382,604
Issuance of common stock for business combination contingent consideration and related tax effects (in shares)		3,127
Issuance of common stock for business combination contingent consideration and related tax effects	498		498
Issuance of replacement awards in connection with business combinations and acquisitions	2,871		2,871
Net income	377,034				377,034
Other comprehensive income (loss), net	$ (7,505)					(7,505)
Ending balance (in shares) at Dec. 31, 2024	76,619,331	76,619,331
Ending balance at Dec. 31, 2024	$ 2,327,665	$ 1	1,689,781	$ (155,947)	812,014	(18,184)
Treasury stock, shares, ending balance (in shares) at Dec. 31, 2024	20,220,227			20,220,227
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		702,536
Issuance of common stock	$ 489,430		489,430
Issuance of common stock under employee plans, net (in shares)		1,324,442
Issuance of common stock under employee plans, net	$ (351,939)		(351,939)
Stock options exercised (in shares)	0
Stock-based compensation	$ 634,231		634,231
Issuance of replacement awards in connection with business combinations and acquisitions	5,295		5,295
Induced conversion of convertible debt (in shares)		1,565,061
Induced conversion of convertible debt	28,365		28,365
Tax effect of partial repurchase and induced conversions of convertible debt	(21,386)		(21,386)
Conversion of convertible debt and shares received from convertible note hedge, net (in shares)		167		13,207
Conversion of convertible debt and shares received from convertible note hedge, net	(37)		1,258	$ (1,295)
Net income	124,656				124,656
Other comprehensive income (loss), net	$ 6,378					6,378
Ending balance (in shares) at Dec. 31, 2025	80,211,537	80,211,537
Ending balance at Dec. 31, 2025	$ 3,242,658	$ 1	$ 2,475,035	$ (157,242)	$ 936,670	$ (11,806)
Treasury stock, shares, ending balance (in shares) at Dec. 31, 2025	20,233,434			20,233,434